Clinical Trial Update: Eptifibatide and ST Segment Resolution Following Primary PCI [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating eptifibatide for ST-segment resolution after primary PCI in myocardial infarction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Integrilin (Eptifibatide)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Myocardial Infarction | Phase 3 | Status: TERMINATED